Vidya Seshadri is an Oncology physician affiliated with Revolution Medicines. OpenAlex indexes 7 publications with 222 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
201 Park St
Bowling Green, KY 421011759
Telephone
270-781-5111Registry record last updated 20 Aug 2019.
Industry payments
102 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- OnMark, Inc.Program year202510 payments
- AstraZeneca Pharmaceuticals LPProgram year202516 payments
- PFIZER INC.Program year202519 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
55.1%Iron, parenteral preparations52.3%Ferric carboxymaltose97%Ferric derisomaltose3%Part B, office-administered≥53 patientsErythropoiesis-stimulating Agent2.7%Epoetin alfa100%Part B, office-administered≥21 patients+ 2 more classes in this area
Cancer & immunology
24.1%PD-1 inhibitor16.4%Pembrolizumab100%Part B, office-administered≥25 patientsCD38-directed Cytolytic Antibody7.2%Daratumumab100%Part B, office-administered≥12 patients+ 12 more classes in this area
Musculoskeletal
11.1%RANK Ligand Inhibitor11.1%Denosumab100%Part B, office-administered≥47 patientsXanthine oxidase inhibitor0%Allopurinol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”